Ignite Creation Date:
2024-10-25 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06613321
Status:
COMPLETED
Last Update Posted:
None
First Post:
2023-10-09
Brief Title:
Lung Hyperinflation and Response to Pulmonary Vasodilator Therapy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Impact of Lung Hyperinflation on the Response to Pulmonary Vasodilator Therapy in Patients with Pulmonary Hypertension PH Associated with Chronic Obstructive Pulmonary Disease COPD
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this retrospective observational study is to evaluate if lung distension disorders can be a predictive factor of bad response to vasodilator therapy in patients with pulmonary hypertension PH associated with chronic obstructive pulmonary disease COPD
The study will include all patients from the hospital followed for pulmonary hypertension associated with COPD under vasodilator therapy between 2015 and 2021
The study will include all patients from the hospital followed for pulmonary hypertension associated with COPD under vasodilator therapy between 2015 and 2021
Detailed Description:
The goal of this retrospective observational study is to evaluate if lung distension disorders can be a predictive factor of bad response to vasodilator therapy in patients with pulmonary hypertension PH associated with chronic obstructive pulmonary disease COPD
The study will include all patients from the hospital followed for PH associated with COPD under vasodilator therapy between 2015 and 2021
It will evaluate patients lung hyperinflation according to the RVTLC ratio and their response to treatment
The study will include all patients from the hospital followed for PH associated with COPD under vasodilator therapy between 2015 and 2021
It will evaluate patients lung hyperinflation according to the RVTLC ratio and their response to treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None